Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial

Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial

Background Key findings from the World Health Organization Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in treating coronavirus disease 2019 (COVID-19) reported that TCMs are beneficial, particularly for mild-to-moderate cases. The efficacy of Jinhua Qinggan granules (JHQG) in...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Muhammad Raza Shah, Samreen Fatima, Sehrosh Naz Khan, Shafi Ullah, Gulshan Himani, Kelvin Wan, Timothy P.H. Lin, Johnson Y. N. Lau, Qingquan Liu, Dennis S.C. Lam
التنسيق: Artigo
اللغة:الإنجليزية
منشور في: 2022
الوصول للمادة أونلاين:https://doi.org/10.3389/fmed.2022.928468
https://www.frontiersin.org/articles/10.3389/fmed.2022.928468/pdf
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

الانترنت

https://doi.org/10.3389/fmed.2022.928468
https://www.frontiersin.org/articles/10.3389/fmed.2022.928468/pdf

مواد مشابهة